Earlier this week, the FNIH held a dinner for the FNIH Board of Directors and other distinguished guests centered on the topic of cancer immunotherapy with members from the scientific community, the advocacy community, industry and government.

Dr. Francis Collins, Director of the National Institutes of Health, Dr. Douglas Lowy, Acting Director of the National Cancer Institute, Dr. Stephen Ostroff, Acting Commissioner of the Food and Drug Administration (FDA) along with Dr. Robert Califf, who is nominated to be the next FDA Commissioner, were in attendance among other sector representatives to discuss the topic and to share ideas in an informal setting